These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 8950237

  • 21. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
    Kaliberov S, Stackhouse MA, Kaliberova L, Zhou T, Buchsbaum DJ.
    Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
    [Abstract] [Full Text] [Related]

  • 22. BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.
    Kornblau SM, Vu HT, Ruvolo P, Estrov Z, O'Brien S, Cortes J, Kantarjian H, Andreeff M, May WS.
    Clin Cancer Res; 2000 Apr; 6(4):1401-9. PubMed ID: 10778970
    [Abstract] [Full Text] [Related]

  • 23. Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment.
    Kobayashi T, Ruan S, Jabbur JR, Consoli U, Clodi K, Shiku H, Owen-Schaub LB, Andreeff M, Reed JC, Zhang W.
    Cell Death Differ; 1998 Jul; 5(7):584-91. PubMed ID: 10200513
    [Abstract] [Full Text] [Related]

  • 24. Trail-induced apoptosis in Type I leukemic cells is not enhanced by overexpression of bax.
    Jia L, Patwari Y, Kelsey SM, Newland AC.
    Biochem Biophys Res Commun; 2001 May 25; 283(5):1037-45. PubMed ID: 11355877
    [Abstract] [Full Text] [Related]

  • 25. Bcl-2/Bax protein ratio predicts 5-fluorouracil sensitivity independently of p53 status.
    Mirjolet JF, Barberi-Heyob M, Didelot C, Peyrat JP, Abecassis J, Millon R, Merlin JL.
    Br J Cancer; 2000 Nov 25; 83(10):1380-6. PubMed ID: 11044365
    [Abstract] [Full Text] [Related]

  • 26. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM, Hulscher TM, Schrier SM, van Houten VM, Pinedo HM, Boven E.
    Gynecol Oncol; 2002 Mar 25; 84(3):404-12. PubMed ID: 11855878
    [Abstract] [Full Text] [Related]

  • 27. Apoptosis in tumor necrosis factor-alpha-dependent, monocyte-mediated leukemic cell death: a functional, morphologic, and flow-cytometric analysis.
    van de Loosdrecht AA, Ossenkoppele GJ, Beelen RH, Broekhoven MG, Dräger AM, Langenhuijsen MM.
    Exp Hematol; 1993 Dec 25; 21(13):1628-39. PubMed ID: 8243565
    [Abstract] [Full Text] [Related]

  • 28. A recessive mutant of the U937 cell line acquired resistance to anti-Fas and anti-p55 tumor necrosis factor receptor antibody-induced apoptosis.
    Noguchi K, Naito M, Kataoka S, Yonehara S, Tsuruo T.
    Cell Growth Differ; 1995 Oct 25; 6(10):1271-7. PubMed ID: 8845304
    [Abstract] [Full Text] [Related]

  • 29. An exogenous cdk inhibitor, butyrolactone-I, induces apoptosis with increased Bax/Bcl-2 ratio in p53-mutated pancreatic cancer cells.
    Wada M, Hosotani R, Lee JU, Doi R, Koshiba T, Fujimoto K, Miyamoto Y, Tsuji S, Nakajima S, Okuyama A, Imamura M.
    Anticancer Res; 1998 Oct 25; 18(4A):2559-66. PubMed ID: 9703910
    [Abstract] [Full Text] [Related]

  • 30. Bax-induction alone is sufficient to activate apoptosis cascade in wild-type Bax-bearing K562 cells, and the initiation of apoptosis requires simultaneous caspase activation.
    Kobayashi T, Sawa H, Morikawa J, Ueno S, Katayama N, Zhang W, Shiku H.
    Int J Oncol; 2002 Apr 25; 20(4):723-8. PubMed ID: 11894116
    [Abstract] [Full Text] [Related]

  • 31. Bax, Bcl-2, and NF-kappaB expression in sanguinarine induced bimodal cell death.
    Weerasinghe P, Hallock S, Liepins A.
    Exp Mol Pathol; 2001 Aug 25; 71(1):89-98. PubMed ID: 11502101
    [Abstract] [Full Text] [Related]

  • 32. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
    Cheong JW, Chong SY, Kim JY, Eom JI, Jeung HK, Maeng HY, Lee ST, Min YH.
    Clin Cancer Res; 2003 Oct 15; 9(13):5018-27. PubMed ID: 14581377
    [Abstract] [Full Text] [Related]

  • 33. Cellular and cytokine dependent monocyte-mediated leukemic cell death: modulation by interferon-gamma and tumor necrosis factor-alpha.
    van de Loosdrecht AA, Beelen RH, Ossenkoppele GJ, Broekhoven MG, Langenhuijsen MM.
    Exp Hematol; 1993 Mar 15; 21(3):461-8. PubMed ID: 8440344
    [Abstract] [Full Text] [Related]

  • 34. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide.
    Chen M, Quintans J, Fuks Z, Thompson C, Kufe DW, Weichselbaum RR.
    Cancer Res; 1995 Mar 01; 55(5):991-4. PubMed ID: 7867010
    [Abstract] [Full Text] [Related]

  • 35. Estradiol increases the Bax/Bcl-2 ratio and induces apoptosis in the anterior pituitary gland.
    Zaldivar V, Magri ML, Zárate S, Jaita G, Eijo G, Radl D, Ferraris J, Pisera D, Seilicovich A.
    Neuroendocrinology; 2009 Mar 01; 90(3):292-300. PubMed ID: 19684383
    [Abstract] [Full Text] [Related]

  • 36. Maturation-dependent susceptibility to monocyte-mediated cytotoxicity in acute myeloid leukemia.
    van de Loosdrecht AA, Ossenkoppele GJ, Beelen RH, Broekhoven MG, van Hooff MH, Dräger AM, Huijgens PC, Langenhuijsen MM.
    Leukemia; 1994 Aug 01; 8(8):1392-400. PubMed ID: 8057679
    [Abstract] [Full Text] [Related]

  • 37. Synthesis of Bcl-2 in response to anthracycline treatment may contribute to an apoptosis-resistant phenotype in leukemic cell lines.
    Durrieu F, Belaud-Rotureau MA, Lacombe F, Dumain P, Reiffers J, Boisseau MR, Bernard P, Belloc F.
    Cytometry; 1999 Jun 01; 36(2):140-9. PubMed ID: 10554162
    [Abstract] [Full Text] [Related]

  • 38. Recombinant immune interferon inhibits leukemic cell growth by a monocyte-macrophage-mediated mechanism.
    Hosoi T, Ozawa K, Ohta M, Okabe T, Urabe A, Takaku F.
    Exp Hematol; 1985 Aug 01; 13(7):597-602. PubMed ID: 3928396
    [Abstract] [Full Text] [Related]

  • 39. A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia.
    van Stijn A, Kok A, van der Pol MA, Feller N, Roemen GM, Westra AH, Ossenkoppele GJ, Schuurhuis GJ.
    Leukemia; 2003 Apr 01; 17(4):780-6. PubMed ID: 12682637
    [Abstract] [Full Text] [Related]

  • 40. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
    Pedrazzoli P, Bains MA, Watson R, Fisher J, Hoy TG, Jacobs A.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):6911-6. PubMed ID: 2684403
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.